Rhythm Pharmaceuticals, Inc.RYTMNASDAQ
Loading
PB Ratio: Premium ValuationElevated
Percentile Rank92
3Y CAGR+105.7%
5Y CAGR+44.7%
Year-over-Year Change
Price-to-book ratio
3Y CAGR
+105.7%/yr
vs +14.1%/yr prior
5Y CAGR
+44.7%/yr
Recent acceleration
Acceleration
+91.6pp
Accelerating
Percentile
P92
Near historical high
vs 5Y Ago
6.3x
Strong expansion
Streak
4 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 50.02 | +141.0% |
| 2024 | 20.75 | +32.9% |
| 2023 | 15.62 | +171.9% |
| 2022 | 5.74 | +229.7% |
| 2021 | 1.74 | -77.9% |
| 2020 | 7.88 | +164.7% |
| 2019 | 2.98 | -12.1% |
| 2018 | 3.38 | -36.9% |
| 2017 | 5.36 | -92.2% |
| 2016 | 68.78 | - |